Headquarters
101 CAMBRIDGEPARK DR FL3, CAMBRIDGE, MA 02140-2910, US
CAMBRIDGE, MA, US
ATAVISTIK BIO, INC.
From the company
Atavistik Bio is a clinical stage biotechnology company developing novel allosteric therapeutics. Its approach enables selective modulation of disease-causing proteins. The company is advancing multiple programs, including its lead asset ATV-1601, an oral allosteric AKT1-selective inhibitor for Hereditary Hemorrhagic Telangiectasia (HHT), and a JAK2 V617F mutant-selective inhibitor program for myeloproliferative neoplasms. It has built a versatile discovery platform that identifies functional pockets across protein classes, with an internal focus on rare
Products & services offered
Capabilities 8
View all 8
Classifications
- Ownership classifications (1)
- Self Certified Small Disadvantaged Business
Facilities
Send your requirements
Quantities, certifications, and timing.